Summit Therapeutics· @SMMT_TX · X·· 3 天前评分45
正文 · 原文
Ivonescimab Data Sets across Multiple Tumor Types to Be Featured at ESMO 2026
Highlights Include Phase II Data Supporting Clinical Development Expansion for Ivonescimab
#ESMO26
https://www.businesswire.com/news/home/20261022076516/en/Ivonescimab-Data-Sets-across-Multiple-Tumor-Types-to-Be-Featured-at-ESMO-2026
715 浏览 · 11 赞 · 5 转发 · 0 回复
来源：Summit Therapeutics · x.com